Long-term Melatonin Administration Attenuates Low-LET Gamma-radiation-induced Lymphatic Tissue Injury During the Reproductively Active and Inactive Phases of Indian Palm Squirrels (Funambulus Pennanti)
Overview
Authors
Affiliations
A comparative analysis of low linear energy transfer (LET) gamma-radiation-induced damage in the lymphatic tissue of a tropical seasonal breeder, Indian palm squirrel (Funambulus pennanti), during its reproductively active phase (RAP) and inactive phase (RIP) was performed with simultaneous investigation of the effects of long-term melatonin pre-treatment (100 microg/100 g body weight). A total of 120 squirrels (60 during RAP and 60 during RIP) were divided into 12 groups and sacrificed at 4, 24, 48, 72 and 168 h following 5 Gy gamma-radiation exposure; control groups were excluded from exposure. Total leukocyte count and absolute lymphocyte count (ALC) and melatonin only of peripheral blood, stimulation index, thiobarbituric-acid-reactive substances (TBARS) level, superoxide dismutase (SOD) activity, and the apoptotic index of spleen as analysed by terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labelling (TUNEL) noted at observed time-points were significantly reduced in melatonin pre-treated groups during RAP and RIP. Long-term melatonin pre-treatment mitigated radiation-induced alterations more prominently during RIP, as assessed by ALC, TBARS, SOD, TUNEL and caspase-3 activity, at some time-points. Our results demonstrate an inhibitory role of melatonin on caspase-3 activity in splenocytes during RAP and RIP following gamma-radiation-induced caspase-mediated apoptosis. Hence, we propose that melatonin might preserve the viability of immune cells of a seasonal breeder against background radiation, which is constantly present in the environment.
Hanedan Uslu G, Canyilmaz E, Serdar L, Ersoz S Mol Clin Oncol. 2019; 10(2):261-266.
PMID: 30680205 PMC: 6327223. DOI: 10.3892/mco.2018.1790.
Naseri S, Noori Moghahi S, Mokhtari T, Roghani M, Shirazi A, Malek F J Mol Neurosci. 2017; 63(2):198-205.
PMID: 28871488 DOI: 10.1007/s12031-017-0970-5.
Canyilmaz E, Hanedan Uslu G, Bahat Z, Kandaz M, Mungan S, Haciislamoglu E Biomed Rep. 2016; 4(1):45-50.
PMID: 26870332 PMC: 4726846. DOI: 10.3892/br.2015.547.
Consequences of lethal-whole-body gamma radiation and possible ameliorative role of melatonin.
Mihandoost E, Shirazi A, Mahdavi S, Aliasgharzadeh A ScientificWorldJournal. 2014; 2014:621570.
PMID: 25431791 PMC: 4238234. DOI: 10.1155/2014/621570.
Can melatonin help us in radiation oncology treatments?.
Mihandoost E, Shirazi A, Mahdavi S, Aliasgharzadeh A Biomed Res Int. 2014; 2014:578137.
PMID: 24900972 PMC: 4037598. DOI: 10.1155/2014/578137.